| 000 | 01817 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517182715.0 | ||
| 264 | 0 | _c20190716 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-017-14587-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenke, Kálmán | |
| 245 | 0 | 0 |
_aPharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation. _h[electronic resource] |
| 260 |
_bScientific reports _c10 2017 |
||
| 300 |
_a14232 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 |
_aCyclic GMP _xblood |
| 650 | 0 | 4 |
_aGemfibrozil _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 |
_aLeukocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xgenetics |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aMátyás, Csaba | |
| 700 | 1 | _aSayour, Alex Ali | |
| 700 | 1 | _aOláh, Attila | |
| 700 | 1 | _aNémeth, Balázs Tamás | |
| 700 | 1 | _aRuppert, Mihály | |
| 700 | 1 | _aSzabó, Gábor | |
| 700 | 1 | _aKökény, Gábor | |
| 700 | 1 | _aHorváth, Eszter Mária | |
| 700 | 1 | _aHartyánszky, István | |
| 700 | 1 | _aSzabolcs, Zoltán | |
| 700 | 1 | _aMerkely, Béla | |
| 700 | 1 | _aRadovits, Tamás | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 14232 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-14587-3 _zAvailable from publisher's website |
| 999 |
_c27731472 _d27731472 |
||